We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
In conjunction with the American Urological Association's Annual Meeting in Atlanta, Cook Urological today announced that it will highlight a new product, Surgisis ES for the treatment of Peyronie's disease.
Endocare, Inc., an innovative medical device company focused on the development of minimally invasive technologies for tissue and tumor ablation, recently unveiled the first cryoablation probe that provides physicians the ability to "sculpt" different sized isotherms (ice balls) to encompass tumors and tissues based on individual patient anatomy and needs.
Minnetronix, a St. Paul, Minn.-based medical device design and manufacturing firm, was the manufacturing category recipient of the 25th Annual "Small Business Award of Excellence," presented by the St. Paul Area Chamber of Commerce.
The FDA's Center for Devices and Radiological Health (CDRH) is making a guidance available that provides agency recommendations on the use of Bayesian statistical methods in the design and analysis of device clinical trials, the agency has announced.
Boston Scientific has warned that some defibrillators produced by its recently acquired subsidiary Guidant may suddenly stop working due to a battery malfunction, adding that it is working to make its postmarket surveillance of device performance more transparent.
Effective August 2, 2006, Minntech Corporation, a wholly owned subsidiary of Cantel Medical Corp. (NYSE: CMN), will sell its industry leading Medivators brand endoscope reprocessing equipment, high-level disinfectants and consumables through its own U.S. sales force.
HCL Technologies Ltd. (HCL), a leading global IT and technology enterprise, May 18 announced that it has established a RoHS compliance management capability for users of medical device companies under its Global Life Sciences & Healthcare Practice.
Data presented at the Heart Rhythm Society's 27th Annual Scientific Sessions finds that during a 10-year study period more than one in five automatic external defibrillators (AEDs) were recalled due to potential malfunction.
Investigators at a single center observed a 1.24% risk of major complications leading to surgical replacement of pulse generators for pacemakers or implantable cardioverter-defibrillators (ICDs), a rate that can help guide discussions with patients when their devices are the target of safety-alert or recall advisories, according to investigators reporting at the Heart Rhythm Society 2006 Scientific Sessions.